Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / Common Stock, $0.0001 Par Value
-
Shares outstanding
-
83,070,866
-
Total 13F shares
-
1,784,212
-
Share change
-
+1,783,580
-
Total reported value
-
$9,117,664
-
Put/Call ratio
-
5.4%
-
Price per share
-
$5.11
-
Number of holders
-
34
-
Value change
-
+$9,114,399
-
Number of buys
-
32
Institutional Holders of Checkpoint Therapeutics, Inc. - Common Stock, $0.0001 Par Value (CKPT) as of Q4 2022
As of 31 Dec 2022,
Checkpoint Therapeutics, Inc. - Common Stock, $0.0001 Par Value (CKPT) was held by
34 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,784,212 shares.
The largest 10 holders included
ARMISTICE CAPITAL, LLC, VANGUARD GROUP INC, BANK OF AMERICA CORP /DE/, BlackRock Inc., GEODE CAPITAL MANAGEMENT, LLC, PVG ASSET MANAGEMENT CORP, Royal Bank of Canada, PARK AVENUE SECURITIES LLC, MILLENNIUM MANAGEMENT LLC, and ADVISOR GROUP HOLDINGS, INC..
This page lists
34
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.